Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.077
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV